Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone plus radiation therapy in active thyroid-associated ophthalmopathy
ChiCTR1800017083Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone in Graves Orbitopathy (GO) (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Clinical activity score. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on ChiCTR1800017083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017083.